Opfindelsen angår farmaceutiske sammensætninger og nærmere bestemt en farmaceutisk sammensætning indeholdende(E)-7 -[ 4-( 4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-ensyre eller et farmaceutisk acceptabelt salt deraf som den aktive bestanddel og et uorganisk salt, hvori kationen er multivalent.The invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing (E) -7 - [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] - (3R, 5S ) -3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof as the active ingredient and an inorganic salt in which the cation is multivalent.
